Thought Leaders RSS Feed - Thought Leaders

News Medical's "Thought Leaders" series is a selection of articles written by national and international experts and trusted advisers in health and medicine. All the articles are written by experts who have been invited as recognised leaders in their fields to provide a "state of the art" contribution.
Advances in telemedicine: an interview with Dr Ameet Bakhai

Advances in telemedicine: an interview with Dr Ameet Bakhai

Telemedicine is the art of improving patient care via managing data remotely, and in this spirit one of the earliest examples often not considered in this category, would be the permanent pacemaker, first implanted into a human being in 1958. [More]
Diagnosing heart attacks in 1 hour: an interview with Dr Richard Body

Diagnosing heart attacks in 1 hour: an interview with Dr Richard Body

Cardiac troponin is a highly sensitive and specific biomarker for myocardial injury but concentrations in the blood rise over several hours after the onset of an acute myocardial infarction. [More]
Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

Innovations in pre-clinical MRI: an interview with Priv. Doz. Dr. Dominik von Elverfeldt

To me the most exciting aspect of pre-clinical imaging is its broad range, from very basic science up to applied science. You deal with a range of disciplines including biology, chemistry, physics, biochemistry, biophysics, cell biology and of course medicine, as the aim is the translation of research to humans. [More]
Using proteomics to understand Alzheimer’s: an interview with Dr Renã Robinson

Using proteomics to understand Alzheimer’s: an interview with Dr Renã Robinson

In our bioanalytical mass spectrometry lab we use proteomics techniques to try to understand more about Alzheimer's disease. The primary thrust of our research is that we're interested in understanding the changes that take place outside of the brain and how those correlate with what's taking place inside the brain [More]
Home screening for bowel cancer: an interview with Deborah Alsina, Chief Executive of Bowel Cancer UK

Home screening for bowel cancer: an interview with Deborah Alsina, Chief Executive of Bowel Cancer UK

FIT (faecal immunochemical test) is a screening test for bowel cancer which detects hidden traces of blood in stools. It is now used in population screening around the world including Italy, The Netherlands, France, Ireland, New Zealand, Australia, Spain, Slovenia, Malta, Japan, parts of Canada, and Southeast Asia. [More]
Tackling superbugs with antibiotic resistance breakers: an interview with Professor Colin Garner, Chief Executive, Antibiotic Research UK

Tackling superbugs with antibiotic resistance breakers: an interview with Professor Colin Garner, Chief Executive, Antibiotic Research UK

Superbugs – or to give them their correct name, antibiotic resistant bacteria – arise on repeated exposure to antibiotics. In any population of bacteria there will be a few that are antibiotic resistant (approximately 1 in 100 million bacteria). If these bacteria are allowed to grow and multiply, an antibiotic resistant infection results. [More]
Advances in NMR metabolomics: an interview with Professor Tone F. Bathen

Advances in NMR metabolomics: an interview with Professor Tone F. Bathen

The main objective of our research is to improve and individualize cancer diagnostics and cancer treatment. We try to achieve this through the integrated use of MR technology and the development of data-driven tools to analyze tumors on both a functional and molecular level. [More]
Explaining asthma to children: an interview with Gabe Ortiz MPAS, PA-C

Explaining asthma to children: an interview with Gabe Ortiz MPAS, PA-C

I think the main challenges in explaining asthma to children, is to make them understand that in most instances it may be a chronic condition that might need chronic daily medicine. [More]
Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.

Understanding idiopathic pulmonary fibrosis: an interview with Michael Durheim, M.D.

IPF is a rare and fatal lung disease that causes permanent scarring of the lungs, leading to debilitating shortness of breath and cough in affected patients. It affects as many as 132,000 Americans, most commonly those over the age of 65. [More]
Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

Zika threat to Olympics attendees? An interview with Prof. Eskild Petersen

The risk in terms of the Olympics, especially for travelling populations remains low – with the notable exception of pregnant women. [More]
The human aspect of simulations through role playing: an interview with Catherine Stoddart

The human aspect of simulations through role playing: an interview with Catherine Stoddart

I think role playing plays an important role, it's a really interesting question because role playing is somewhere on that spectrum of simulation. There is the potential for patients to play a role to relive an experience or an actor can be used. [More]
NHS: a health service or an illness service? An interview with Dr Paula Crick

NHS: a health service or an illness service? An interview with Dr Paula Crick

I've been a nurse for almost 32 years and one of the things that has always been difficult for me to comprehend is that all too often we treat people who are sick, having missed opportunities to prevent, screen or intervene. [More]
Preventing blindness through portable eye examinations: an interview with Dr Mario Ettore Giardini

Preventing blindness through portable eye examinations: an interview with Dr Mario Ettore Giardini

The number of blind people is high. In 2010, the World Health Organisation estimated that, throughout the world, approximately 39 million people are blind. [More]
Molecular basis for tongue cancer progression: an interview with Dr Simona Principe

Molecular basis for tongue cancer progression: an interview with Dr Simona Principe

Head and neck cancers (HNC) are the sixth most common cancers worldwide, with approximately 600,000 new cases diagnosed every year. [More]
Could prebiotics benefit early life brain development? An interview with Dr Phil Burnet

Could prebiotics benefit early life brain development? An interview with Dr Phil Burnet

Galacto-oligosaccharides are essentially sugar or saccharide molecules that have been joined together into short polymer chains. [More]
Could environmental toxins trigger amyloid plaques in the brain? An interview with Dr Paul Alan Cox

Could environmental toxins trigger amyloid plaques in the brain? An interview with Dr Paul Alan Cox

Many Chamorro villagers on the island of Guam perished from a puzzling paralytic disease that combines aspects of ALS, Alzheimer's, and Parkinson's disease. [More]
Delivering microRNAs in cancer treatment: an interview with Dr Conde and Prof Artzi

Delivering microRNAs in cancer treatment: an interview with Dr Conde and Prof Artzi

microRNAs (miRs) are small endogenous noncoding RNA molecules (20–23 nucleotides) derived from imperfectly paired hairpin RNA structures naturally encoded in the genome that act specifically as triggering molecules to control translational repression or mRNA degradation. [More]
Is the global diet getting sweeter? An interview with Professor Barry Popkin

Is the global diet getting sweeter? An interview with Professor Barry Popkin

In the past, caloric sweeteners simply referred to cane sugar or beet sugar. However, over time we've created hundreds of different sugars that are all providing calories of the same amount, about four calories for every gram of the sugar. Some examples include corn syrups and more processed sweeteners like high fructose corn syrup. [More]
Systemic sclerosis: an interview with Dr Kristin Highland

Systemic sclerosis: an interview with Dr Kristin Highland

Systemic sclerosis, also known as scleroderma, is a rare disease characterized by the thickening and scarring of connective tissue of multiple organs in the body [More]
Psychological difficulties of ovarian cancer: an interview with Katherine Taylor

Psychological difficulties of ovarian cancer: an interview with Katherine Taylor

Ovarian cancer affects around 7000 thousand women in the UK every year and very sadly the outcomes are not great. A women dies every 2 hours of ovarian cancer. If I am diagnosed today, I’ve only got a 40% chance of being alive in 5 years’ time. [More]
Advertisement
Advertisement